Anti-urease immunoglobulin (IgY) from egg yolk prevents Helicobacter pylori infection in a mouse model

References

• Aebischer, T., Schmitt, A., Walduck, A. K., & Meyer, T. F. (2005). Helicobacter pylori vaccine development: Facing the challenge. International Journal of Medical Microbiology, 295, 343–353. doi: 10.1016/j.ijmm.2005.06.005
   PubMed Web of Science ®Google Scholar
• Akita, E. M., Li-Chan, E. C. Y., & Nakai, S. (1998). Neutralization of enterotoxigenic Escherichia coli heat-labile toxin by chicken egg yolk immunoglobulin Y and its antigen-binding fragments. Food and Agricultural Immunology, 10(2), 161–172. doi: 10.1080/09540109809354979
   Web of Science ®Google Scholar
• Ayala, G., Escobedo-Hinojosa, W. I., de la Cruz-Herrera, C. F., & Romero, I. (2014). Exploring alternative treatments for Helicobacter pylori infection. World Journal of Gastroenterology, 20, 1450–1469. doi: 10.3748/wjg.v20.i6.1450
   PubMed Web of Science ®Google Scholar
• Backert, S., Neddermann, M., Maubach, G., & Naumann, M. (2016). Pathogenesis of Helicobacter pylori infection. Helicobacter, 21, 19–25. doi: 10.1111/hel.12335
   PubMedGoogle Scholar
• Backert, S., Tegtmeyer, N., & Selbach, M. (2010). The versatility of Helicobacter pylori CagA effector protein functions: The master key hypothesis. Helicobacter, 15, 163–176. doi: 10.1111/j.1523-5378.2010.00759.x
   PubMed Web of Science ®Google Scholar
• Berger, H., Marques, M. S., Zietlow, R., Meyer, T. F., Machado, J. C., & Figueiredo, C. (2016). Gastric cancer pathogenesis. Helicobacter, 21, 34–38. doi: 10.1111/hel.12338
   PubMed Web of Science ®Google Scholar
• Clyne, M., Dolan, B., & Reeves, E. P. (2007). Bacterial factors that mediate colonization of the stomach and virulence of Helicobacter pylori. FEMS Microbiology Letters, 268, 135–143. doi: 10.1111/j.1574-6968.2007.00648.x
   PubMed Web of Science ®Google Scholar
• Czinn, S. J., & Blanchard, T. (2011). Vaccinating against Helicobacter pylori infection. Nature Reviews Gastroenterology & Hepatology, 8, 133–140. doi: 10.1038/nrgastro.2011.1
   PubMed Web of Science ®Google Scholar
• De Meulenaer, B., & Huyghebaert, A. (2001). Isolation and purification of chicken egg yolk immunoglobulins: A review. Food and Agricultural Immunology, 13(4), 275–288. doi: 10.1080/09540100120094537
   Web of Science ®Google Scholar
• Diraviyam, T., Zhao, B., Wang, Y., Schade, R., Michael, A., & Zhang, X. (2014). Effect of chicken egg yolk antibodies (IgY) against diarrhea in domesticated animals: A systematic review and meta-analysis. PLoS One, 9((5)), e97716. doi: 10.1371/journal.pone.0097716
   PubMed Web of Science ®Google Scholar
• Dubois, A., Lee, C. K., Fiala, N., Kleanthous, H., Mehlman, P. T., & Monath, T. (1998). Immunization against natural Helicobacter pylori infection in nonhuman primates. Infection and Immunity, 66, 4340.
   PubMed Web of Science ®Google Scholar
• Foegeding, N., Caston, R., McClain, M., Ohi, M., & Cover, T. (2016). An overview of Helicobacter pylori VacA toxin biology. Toxins, 8, 173. doi: 10.3390/toxins8060173
   PubMed Web of Science ®Google Scholar
• Hong, K. S., Ki, M. R., Ullah, H. M. A., Lee, E. J., Kim, Y. D., Chung, M. J., … Jeong, K. S. (2018). Preventive effect of anti-VacA egg yolk immunoglobulin (IgY) on Helicobacter pylori-infected mice. Vac, 36(3), 371–380.
   Google Scholar
• Huang, J. Y., Sweeney, E. G., Guillemin, K., & Amieva, M. R. (2017). Multiple acid Sensors control Helicobacter pylori colonization of the stomach. PLOS Pathogens, 13(1), e1006118. doi: 10.1371/journal.ppat.1006118
   PubMed Web of Science ®Google Scholar
• Israel, D. A., & Peek, R. M. (2001). Review article: Pathogenesis of Helicobacter pylori-induced gastric inflammation. Alimentary Pharmacology and Therapeutics, 15, 1271–1290. doi: 10.1046/j.1365-2036.2001.01052.x
   PubMed Web of Science ®Google Scholar
• Jaradat, Z. W., & Marquardt, R. R. (2010). Studies on the Stability of chicken IgY in different sugars, complex carbohydrates and food materials. Food and Agricultural Immunology, 12(4), 263–272. doi: 10.1080/09540100020008137
   Google Scholar
• Kabir, S. (2007). The current status of Helicobacter pylori vaccines: A review. Helicobacter, 12, 89–102. doi: 10.1111/j.1523-5378.2007.00478.x
   PubMed Web of Science ®Google Scholar
• Kao, C. Y., Sheu, B. S., & Wu, J. J. (2016). Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis. Biomedical Journal, 39(1), 14–23. doi: 10.1016/j.bj.2015.06.002
   PubMed Web of Science ®Google Scholar
• Ki, M. R., Hwang, M., Kim, A. Y., Lee, E. M., Lee, E. J., & Lee, M. M. (2014). Role of vacuolating cytotoxin VacA and cytotoxin-associated antigen CagA of Helicobacter pylori in the progression of gastric cancer. Molecular and Cellular Biochemistry, 396, 23–32. doi: 10.1007/s11010-014-2138-8
   PubMed Web of Science ®Google Scholar
• Koesling, J., Lucas, B., Develioglou, L., Aebischer, T., & Meyer, T. F. (2001). Vaccination of mice with live recombinant Salmonella ryphimurium aro A against H. Pylori: Parameters associated with prophylactic and therapeutic vaccine efficacy. Vac, 12(413), 420.
   Google Scholar
• Kwak, H. W., Choi, I. J., Cho, S. J., Lee, J. Y., & Kim, C. G. (2014). Characteristics of gastric cancer according to Helicobacter pylori infection status. Journal of Gastroenterology and Hepatology, 29, 1671–1677. doi: 10.1111/jgh.12605
   PubMed Web of Science ®Google Scholar
• Ky, K., & Ahn, D. U. (2007). Preparation of immunoglobulin Y from egg yolk using ammonium sulfate precipitation and ion exchange chromatography. Poultry Science, 86(2), 400–407. doi: 10.1093/ps/86.2.400
   PubMed Web of Science ®Google Scholar
• Malekshahi, Z. V., Gargari, S. L., Rasooli, I., & Ebrahimizadeh, W. (2011). Treatment of Helicobacter pylori infection in mice with oral administration of egg yolk-driven anti-UreC immunoglobulin. Microbial Pathogenesis, 51(5), 366–372. doi: 10.1016/j.micpath.2011.06.002
   PubMed Web of Science ®Google Scholar
• Michetti, P., Corthésy-Theulaz, I., Davin, C., Haas, R., Vaney, A.-C., Heitz, M., … Blum, A. (1994). Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology, 107, 1002–1011. doi: 10.1016/0016-5085(94)90224-0
   PubMed Web of Science ®Google Scholar
• Milani, M., Sharifi, Y., Rahmati, Y. M., Somi, M. H., & Akbarzadeh, A. (2015). Immunology and vaccines and nano vaccines for Helicobacter pylori infection. Expert Review of Vaccines, 14, 833–840. doi: 10.1586/14760584.2015.1008460
   PubMed Web of Science ®Google Scholar
• Nelson, R., Katayama, S., Mine, Y., & Duarte, J. (2007). Immunomodulating effects of egg yolk low lipid peptic digests in a murine model. Food and Agricultural Immunology, 18(1), 1–15. doi: 10.1080/09540100601178623
   Web of Science ®Google Scholar
• Palframan, S. L., Kwok, T., & Gabriel, K. (2012). Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis. Frontiers in Cellular and Infection Microbiology, 2, 92. doi: 10.3389/fcimb.2012.00092
   PubMed Web of Science ®Google Scholar
• Phadnis, S. H., Parlow, M. H., Levy, M., Ilver, D., Caulkins, C. M., Connors, J. B., & Dunn, B. E. (1996). Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis. Infection and Immunity, 64, 905–912.
   PubMed Web of Science ®Google Scholar
• Plummer, M., Franceschi, S., Vignat, J., Forman, D., & de Martel, C. (2015). Global burden of gastric cancer attributable to Helicobacter pylori. International Journal of Cancer, 136, 487–490. doi: 10.1002/ijc.28999
   PubMed Web of Science ®Google Scholar
• Punyokun, K., Hongprayoon, R., Srisapoome, P., & Sirinarumitr, T. (2013). The production of anti-vibrio harveyi egg yolk immunoglobulin and evaluation of its stability and neutralisation efficacy. Food and Agricultural Immunology, 24(3), 279–294. doi: 10.1080/09540105.2012.684203
   Web of Science ®Google Scholar
• Rahman, S., Van, N. S., Icatlo Jr, F. C., Umeda, K., & Kodama, Y. (2013). Oral passive IgY-based immune therapeutics. A novel solution for prevention and treatment of alimentary tract diseases. Human Vaccines & Immunotherapeutics, 9, 1039–1048. doi: 10.4161/hv.23383
   PubMed Web of Science ®Google Scholar
• Shin, J. H., Nan, S. W., Kim, J. T., Yoon, J. B., Bang, W. G., & Roe, I. H. (2003). Identification of immunodominant Helicobacter pylori proteins with reactivity to H. Pylori-specific egg-yolk immunoglobulin. Journal of Medical Microbiology, 52, 217–222. doi: 10.1099/jmm.0.04978-0
   PubMed Web of Science ®Google Scholar
• Shin, J. H., Yang, M., Nam, S. W., Kim, J. T., Myung, N. H., Bang, W. G., & Roe, I. H. (2002). Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of H. Pylori infection. Clinical and Diagnostic Laboratory Immunology, 9, 1061–1066.
   PubMedGoogle Scholar
• Shiota, S., Suzuki, R., & Yamaoka, Y. (2013). The significance of virulence factors in Helicobacter pylori. Journal of Digestive Diseases, 14, 341–349. doi: 10.1111/1751-2980.12054
   PubMed Web of Science ®Google Scholar
• Sutton, P., & Lee, A. (2011). Helicobacter pylori vaccines-the current status. Alimentary Pharmacology and Therapeutics, 14, 1107–1118. doi: 10.1046/j.1365-2036.2000.00825.x
   Google Scholar
• Suzuki, H., Nomura, S., Masaoka, T., Goshima, H., Kamata, N., Kodama, Y., … Hibi, T. (2004). Effect of dietary anti-Helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics, 20, 185–192. doi: 10.1111/j.1365-2036.2004.02027.x
   PubMed Web of Science ®Google Scholar
• Svennerholm, A. M., & Lundgren, A. (2007). Progress in vaccine development against Helicobacter pylori. FEMS Immunology & Medical Microbiology, 50, 146–156. doi: 10.1111/j.1574-695X.2007.00237.x
   PubMedGoogle Scholar
• Tatematsu, M., Tsukamoto, T., & Mizoshita, T. (2005). Role of Helicobacter pylori in gastric carcinogenesis: The origin of gastric cancers and heterotopic proliferative glands in Mongolian gerbils. Helicobacter, 10, 97–106. doi: 10.1111/j.1523-5378.2005.00305.x
   PubMed Web of Science ®Google Scholar
• Wang, B., Yang, J., Cao, S., Wang, H., & Pan, X. (2014). Preparation of specific anti-Helicobacter pylori yolk antibodies and their antibacterial effects. International Journal of Clinical and Experimental Pathology, 7, 6430–6637.
   PubMed Web of Science ®Google Scholar
• Yong, X., Tang, B., Li, B. S., Xie, R., Hu, C. J., Luo, G., … Yang, S. M. (2015). Helocobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways. Cell Comm Sig, 30, 13.
   Google Scholar
• Zajac, J., Schubert, A., Dyek, T., & Oelkrung, C. (2017). Igy antibodies for the prevention and treatment of Helicobacter pylori infections. Journal of Medical Microbiology & Diagnosis, 6, 2–5. doi: 10.4172/2161-0703.1000254
   Google Scholar